Cargando…

A Validation Study of Administrative Claims Data to Measure Ovarian Cancer Recurrence and Secondary Debulking Surgery

OBJECTIVE: Administrative claims data offer an alternative to chart abstraction to assess ovarian cancer recurrence, treatment and outcomes. Such analyses have been hindered by lack of valid recurrence and treatment algorithms. In this study, we sought to develop claims-based algorithms to identify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Livaudais-Toman, Jennifer, Egorova, Natalia, Franco, Rebeca, Prasad-Hayes, Monica, Howell, Elizabeth A., Wisnivesky, Juan, Bickell, Nina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AcademyHealth 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108632/ https://www.ncbi.nlm.nih.gov/pubmed/27891525 http://dx.doi.org/10.13063/2327-9214.1208

Ejemplares similares

Challenges of implementation and implementation research: Learning from an intervention study designed to improve tumor registry reporting
por: McAlearney, Ann Scheck, et al.
Publicado: (2016)

Secondary debulking for ovarian carcinoma relapse: The R-R dilemma – is the prognosis different for residual or recurrent disease?
por: Spiliotis, John D., et al.
Publicado: (2019)

Quinary debulking for epithelial ovarian cancer
por: Edwards, James M., et al.
Publicado: (2012)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
por: Sørensen, Sarah Mejer, et al.
Publicado: (2022)

Model for Prediction of Optimal Debulking of Epithelial Ovarian Cancer
por: Arab, Maliheh, et al.
Publicado: (2018)

Does Endometriosis Hinder Successful Ovarian Debulking Surgery?
por: Sananpanichkul, Panya, et al.
Publicado: (2018)

Bronchoscopic debulking for endobronchial malignancy: Predictors of recanalization and recurrence
por: Kuo, Scott Chih-Hsi, et al.
Publicado: (2015)

Safety and Efficacy of Video Laparoscopic Surgical Debulking of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
por: Nezhat, Farr R., et al.
Publicado: (2012)

Diaphragm hernia after debulking surgery in patients with ovarian cancer
por: Ehmann, Sarah, et al.
Publicado: (2021)

Role of Neoadjuvant Chemotherapy in Ovarian Serous Cancer Followed by Debulking
por: Chauhan, Sonali, et al.
Publicado: (2022)

Current status of tertiary debulking surgery and prognosis after secondary debulking surgery for recurrent Müllerian epithelial cancer in Japan: a retrospective analysis of 164 patients (KCOG-G1402)
por: Hirakawa, Tomoko, et al.
Publicado: (2017)

Recurrent ovarian steroid cell tumor, not otherwise specified managed with debulking surgery, radiofrequency ablation, and adjuvant chemotherapy
por: Kim, Jin Suk, et al.
Publicado: (2014)

KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer
por: Zhao, Haiyue, et al.
Publicado: (2016)

Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer
por: Günakan, Emre, et al.
Publicado: (2020)

Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
por: Yokosu, Kota, et al.
Publicado: (2021)

Postoperative paralytic ileus following debulking surgery in ovarian cancer patients
por: Egger, Eva K., et al.
Publicado: (2022)

Septic Shock Secondary to Tricuspid Valve Vegetation Requiring Surgical Debulking
por: Gorantla, Asher, et al.
Publicado: (2023)

Breast cancer patients’ recall of receiving patient assistance services
por: Lin, Jenny J, et al.
Publicado: (2012)

Mammography facilities serving vulnerable women have longer follow‐up times
por: Karliner, Leah S., et al.
Publicado: (2018)

Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancer
por: Derlatka, Pawel, et al.
Publicado: (2016)

Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers
por: Tsoi, Tung Tung, et al.
Publicado: (2020)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

Predictors of residual disease after debulking surgery in advanced stage ovarian cancer
por: Abbas-Aghababazadeh, Farnoosh, et al.
Publicado: (2023)

Robot-assisted laparoscopic debulking surgery for recurrent adult granulosa cell tumors
por: Groeneweg, Jolijn W., et al.
Publicado: (2021)

Salvage debulking surgery and hyperthermic intrathoracic chemotherapy for massive recurrent mesothelioma in the mediastinum
por: Poon, Shi Sum, et al.
Publicado: (2022)

Prevalence of claims-based recurrent low back pain in a Canadian population: A secondary analysis of an administrative database
por: Beaudet, Nicolas, et al.
Publicado: (2013)

Cost of comprehensive patient assistance program in early breast cancer patients
por: Stey, Anne M, et al.
Publicado: (2013)

Utilization of Oncotype DX in an Inner City Population: Race or Place?
por: Guth, Amber A., et al.
Publicado: (2013)

The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer
por: Vitarello, John, et al.
Publicado: (2021)

Debulking mastectomy with electrochemotherapy: a case report of no surgery approach to recurrent breast cancer
por: Esposito, Emanuela, et al.
Publicado: (2021)

Latino and Black smokers in the Health and Retirement Study are more likely to quit: the role of light smoking
por: Bandiera, Frank C., et al.
Publicado: (2016)

Increasing Telehealth Access to Care for Older Adults During the COVID-19 Pandemic at an Academic Medical Center: Video Visits for Elders Project (VVEP)
por: Chu, Janet N., et al.
Publicado: (2022)

Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
por: Christie, Alan, et al.
Publicado: (2013)

Safety and feasibility of robotic surgery in selected ovarian cancer patients undergoing interval debulking surgery
por: Iavazzo, Christos, et al.
Publicado: (2020)

Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
por: Liu, Ying L., et al.
Publicado: (2019)

Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer
por: YANG, ZHIJUN, et al.
Publicado: (2013)

Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
por: Iwase, Haruko, et al.
Publicado: (2015)

The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Prognostic Significance of Systematic Lymphadenectomy in Patients With Optimally Debulked Advanced Ovarian Cancer: A Meta-Analysis
por: Wang, Yizi, et al.
Publicado: (2020)

Minimally invasive repair of a left diaphragm hernia after debulking surgery for advanced ovarian cancer
por: Ehmann, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p8un8grlov2eiisshp8m89gt1a